arrow
J

John Moppett

bristol royal hospital for children
H指数:29
被引数:2,367

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

EARLY RESPONSE AND GENETICS DEFINE RELAPSE RISK AFTER FRONTLINE BLINATUMOMAB IN CHILDHOOD B-ALL: A COHORT STUDY

早期反应和遗传学定义儿童B-ALL一线治疗布利塔尼单抗后的复发风险:一项队列研究

2026-01-010
OA
Guidelines from the expert advisory committee on the Safety of Blood, Tissues and Organs (SaBTO) on patient consent and shared decision-making for blood transfusion

输血患者知情同意与共同决策的指南(来自血液、组织及器官安全专家咨询委员会SaBTO)

2025-09-090
OAAI
Blinatumomab with De-Escalated Chemotherapy for Infant KMT2A-Rearranged B-Cell Acute Lymphoblastic Leukemia

Blinatumomab联合降阶梯化疗治疗婴儿KMT2A重排B细胞急性淋巴细胞白血病

BLOOD
IF23.1
2024-11-052
PRE
Cerebrospinal Fluid Flow Cytometry Improves Patient Stratification in Central Nervous System Acute Lymphoblastic Leukaemia but Requires Careful Standardization: Results from the ALLTogether1 CSF-FLOW Sub-Study

脑脊液流式细胞术改善了中枢神经系统急性淋巴细胞白血病患者分层,但需要仔细标准化:ALLTogether1 CSF-FLOW子研究结果

BLOOD
IF23.1
2024-11-050
PRE
Alemtuzumab, Dual Graft-versus-Host Disease Prophylaxis, and Lower CD3+ T Cell Doses Equalize Rates of Acute and Chronic Graft-versus-Host Disease in Pediatric Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation with Matched Unrelated Donor Peripheral Blood Stem Cells or Bone Marrow Grafts
2024-03-010
OAAI
Shiga toxin targets the podocyte causing hemolytic uremic syndrome through endothelial complement activation

志贺毒素通过内皮补体激活靶向足细胞引起溶血性尿毒症综合征

MED
IF11.8
2023-11-013
OAAI
Molecular characterization and clinical outcome of B-cell precursor acute lymphoblastic leukemia with IG-MYC rearrangement
2022-04-2815
OAAI
Standardized next-generation sequencing of immunoglobulin and T-cell receptor gene recombinations for MRD marker identification in acute lymphoblastic leukaemia; a EuroClonality-NGS validation study

免疫球蛋白和T细胞受体基因重组的标准化下一代测序用于急性淋巴细胞白血病的MRD标记鉴定; 欧洲克隆性-NGS验证研究

LEUKEMIA
IF13.4
2019-06-26175
OAAI
Quality control and quantification in IG/TR next-generation sequencing marker identification: protocols and bioinformatic functionalities by EuroClonality-NGS
LEUKEMIA
IF13.4
2019-06-2166
OAAI